Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia - Wikidata - awgldk - TriplyDB

Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia

Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q27025242

about

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias Drugging the unfolded protein response in acute leukemias An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations.The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.Novel methods and approaches to acute lymphoblastic leukemia drug discovery.Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.Novel agents for the treatment of childhood leukemia: an update.Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.Dasatinib for a child with Philadelphia chromosome-positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy Philadelphia chromosome-like acute lymphoblastic leukemia.How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia.T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy.The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib.New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.

P2860

Q26769590-F5503B95-02FB-432D-A41A-0FA2C8250562 Q26801114-BAE82A71-FED2-4FD2-8774-37FD2223844C Q34233335-42D40271-70FA-4249-B205-ED2DA7BF9A16 Q36267151-7B4C67A8-714C-47FC-B305-979E189B5755 Q36811503-3B0A117F-0C3A-40BA-AE03-6F6722B2A50A Q36833021-9D62CEFF-328C-49A0-842C-A955CA0505A7 Q38248461-830652B0-5BF9-4847-8D2D-29353285B2CF Q38261268-627DDE42-EA66-4CF7-9D97-89CBE9F1D7BB Q38381463-81E758D2-4098-4D2F-BBA5-ED5D847DEE38 Q38698520-BDD6A4DA-229A-4AB8-92B5-27362DB8E66E Q38699035-F5043375-7899-4C0B-A68C-27389240146D Q39455649-88BDEC9F-4E83-4665-88AE-EBCF9A2C4A2A Q39751939-7F506AA0-0105-4D40-979F-6E325C5BF64E Q41863632-32D15659-2FC4-4A46-81AE-204BF6FA0A94 Q43431904-9631758C-887A-459A-BD29-6D36073C196E Q44275292-D7659E94-7832-4181-B290-C5C0782568C6 Q47150923-93214703-1CEF-4159-9EF8-E645ED37B044 Q51363096-562C73CF-134E-4655-8D43-141F562C96AC Q51439967-457D086D-3FCA-4F25-806F-EDE87833C8A2 Q52593673-1E7ED734-CECF-45CD-AF07-ACC98056E0E9

P2860

Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q27025242

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@ast

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@en

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@nl

type

label

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@ast

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@en

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@nl

prefLabel

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@ast

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@en

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@nl

P1433

Q27025242-C0CE2A85-D937-4B8E-A1E5-7986456AFAEC

P1476

Q27025242-8958DDAA-F1A6-40AA-9886-A8123E72E453

P2093

Q27025242-EDE01BA0-C046-42EF-856D-EC4E68EED42E

P2860

Q27025242-0088DA31-931C-455B-AD5D-CF2888AA2300

Q27025242-05569C83-A50A-4E2C-A90E-07464BC94F7F

Q27025242-0716A15A-7633-4644-A534-9E31EFA3ABAF

Q27025242-08A75AB5-4848-44CB-A9D9-477B520885EE

Q27025242-093492A9-738D-442B-B01F-7283991CBA8C

Q27025242-09AF8146-CEED-4783-A992-BFFEA3B8E8AD

Q27025242-0B47829F-AADA-41BF-82BC-B936E1C21CEE

Q27025242-0D0CE60F-A727-4165-A4ED-A564C1D07885

Q27025242-0E0EFE7D-409E-4709-8D97-D17029367BA4

Q27025242-0FB4BA78-775D-4CCE-8F2A-B03AA306BB5F

P304

Q27025242-8FB1C2D3-EDD3-4FF1-ABEF-C9D7C92C3050

P31

Q27025242-DC2806E9-46EF-46DE-A1DE-50429E5AB41B

P3181

Q27025242-1CEC8E75-C4C5-4EC8-97DF-A0C4F0DA18C1

P356

Q27025242-083B66E2-1565-4CB7-A593-23BC4782728D

P407

Q27025242-AF1DA5A7-1E3C-4FD3-815E-B4D550C0832E

P478

Q27025242-8B6E5431-3812-4D38-9F80-D8CEE69E559F

P50

Q27025242-2E8C4BB0-601B-44B1-ABDF-4A79166865AE

Q27025242-63B6BFBE-87C2-4318-8015-763AE0346AA3

P577

Q27025242-979FDABB-5CDA-4AC5-A008-727E4FA1028F

P5875

Q27025242-ABEC50E6-C718-4935-BD14-FD12391A6C56

P698

Q27025242-3671CE78-85B6-4DA5-B413-97FBFDD8DBD8

P921

Q27025242-B5C1F3CB-502F-4FB1-B91F-12C2DBEEF396

P932

Q27025242-88869315-6F4C-48F0-9CD3-E511D86AA2CD

P3181

P356

FONC.2014.00054

P1433

Frontiers in Oncology

P1476

Current concepts in pediatric ...... e acute lymphoblastic leukemia

@en

P2093

Stephen P Hunger

http://www.w3.org/2001/XMLSchema#string

P2860

The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase

STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia

The BCR gene encodes a novel serine/threonine kinase activity within a single exon

Role of Ikaros in T-cell acute lymphoblastic leukemia

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

P304

54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2253581

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FONC.2014.00054

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Kathrin M. Bernt

Kathrin M Bernt

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261605213

http://www.w3.org/2001/XMLSchema#string

P698

24724051

http://www.w3.org/2001/XMLSchema#string

P921

P932

3971203

http://www.w3.org/2001/XMLSchema#string